MedTrace Logo

Molecular, Metabolomic and Nutritional Changes After Metabolic Surgery

NCT05322551 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 102

Last updated 2022-09-01

No results posted yet for this study

Summary

Obesity is a major risk factor for Type 2 Diabetes (T2D) and cardiovascular diseases, such as hypertension and dyslipidemia. Recently, weight loss surgery (i.e., metabolic or bariatric surgery) has been shown to result in very good long-term glycemic control in patients with T2D and obesity. However, knowledge and data on molecular levels and metabolomics are still limited. This study will fill in these gaps and provide potential biomarkers for T2D. Lifestyle and dietary practices (LDP) influence the clinical outcome and metabolites in T2D. Although the roles of LDP is critical in ensuring optimal clinical outcomes, data is still limited especially on relating the LDP and metabolomics in T2D.

Conditions

Sponsors & Collaborators

  • Universiti Putra Malaysia

    collaborator OTHER

  • Ministry of Health, Malaysia

    lead OTHER_GOV

Principal Investigators

  • Fazliana Mansor, PhD · Institute for Medical Research, Setia Alam, Malaysia

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-24
Primary Completion
2023-01-31
Completion
2024-12-31

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05322551 on ClinicalTrials.gov